Related Experiment Video
Updated: Jun 16, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Calcium dysregulation in amyotrophic lateral sclerosis
Julian Grosskreutz1, Ludo Van Den Bosch, Bernhard U Keller
1Dept. of Neurology, Friedrich-Schiller University Hospital Jena, Erlanger Allee 101, 07747 Jena, Germany. julian.grosskreutz@med.uni-jena.de
Amyotrophic lateral sclerosis (ALS) involves motor neuron death due to calcium dysregulation. A toxic shift in the endoplasmic reticulum-mitochondria calcium cycle (ERMCC) is proposed as a key mechanism driving neurodegeneration.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron degeneration.
- Key pathological hallmarks include organelle fragmentation, oxidative stress, mitochondrial calcium overload, and protein aggregation.
- Specific motor neuron populations with reduced calcium-buffering capacity are particularly susceptible.
Purpose of the Study:
- To review the role of calcium dysregulation in motor neuron degeneration in ALS.
- To introduce the "toxic shift of Ca2+" hypothesis within the endoplasmic reticulum-mitochondria calcium cycle (ERMCC).
- To identify potential molecular targets for novel neuroprotective therapies.
Main Methods:
- Review of existing literature on ALS pathogenesis and calcium signaling.
- Analysis of the interplay between endoplasmic reticulum and mitochondria in calcium homeostasis.
- Discussion of excitotoxicity mediated by AMPA receptors in ALS.
Main Results:
- Chronic excitotoxicity via Ca2+-permeable AMPA receptors contributes to intracellular Ca2+ dysregulation in ALS.
- This dysregulation leads to endoplasmic reticulum Ca2+ depletion and mitochondrial Ca2+ overload.
- Riluzole, a current treatment, may exert its effects by reducing glutamatergic input.
Conclusions:
- A "toxic shift of Ca2+" within the ERMCC is hypothesized as a central mechanism in ALS motor neuron death.
- Targeting the ERMCC offers potential for developing new neuroprotective strategies for ALS.
- Further research into ERMCC-modulating therapies is warranted.
Related Concept Videos
Alterations in Muscle Tone lll
Cross-bridge Cycle
Neural Regulation
Alzheimer Disease ll: Pathophysiology
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

